Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an ...

Chai Discovery, a company that uses AI to predict and reprogram interactions between biochemical molecules, has secured $70 million in a Series A funding in a round led by Menlo Ventures, with an ...

A new artificial intelligence model could help design antibodies that better protect the body against viruses and disease.

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease. Experts from the University of ...

During this unique study, scientists sought to understand if artificial intelligence could be used to predict how the ...

Antibodies are one of the most active areas of therapeutics development, with the global antibody market valued at $210 billion in 2022 and projected to reach almost half a trillion by 2030. These ...

One of the most lethal forms of breast cancer has long shrugged off the best drugs in the oncologist’s arsenal, leaving ...

Antibodies have evolved by nature to possess exquisite selectivity for foreign targets to elicit an effective immune response, making particularly promising strides in advancing drug development for ...

Artificial intelligence (AI) and “protein language” models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

AI can move beyond prediction to purposeful molecular design, creating proteins that meet clearly defined research and therapeutic goals.

Galux signed a research agreement with Boehringer Ingelheim to advance AI-driven precision protein design for next-generation ...